More African countries set to approve malaria shot; 20 million doses ready in 2023 | ANG
  • September 21, 2023

Nigerian president says there should be equal partnerships with Africa

In his inaugural speech at the United Nations, Nigeria’s president, Bola Tinubu, emphasised the need for Africa to overcome the constraints of foreign exploitation and unlock its vast potential. “Failures in …

DR Congo calls for swift withdrawal of UN peacekeepers

The president of the Democratic Republic of Congo on Wednesday called for a speedy withdrawal of a key UN peacekeeping mission that has been in the nation for nearly 25 years. …

Bazoum wants regional court to reinstate him as President of Niger

The deposed president of Niger, Mohamed Bazoum, has decided to take his case to the West African justice system to obtain his release and the restoration of constitutional order in the …

African countries are lining up to approve a new vaccine for malaria, with 20 million doses available for them to buy this year, the shot’s manufacturer told Reuters.

This week, Nigeria’s pharmaceutical regulatory authority has joined Ghana in supporting the new R21 vaccine, making them the first countries globally to do so. This vaccine was developed by Oxford University scientists and manufactured by the Serum Institute of India.

African countries that do not have extensive resources for drug regulation have previously relied on the U.N. agency to initially review new medicines.

At present, there is a lack of public access to comprehensive information regarding the malaria vaccine’s outcomes in large-scale trials. Additionally, it remains uncertain how low-income countries will afford the cost of the vaccination.

However, the urgency of addressing a disease that kills more than 600,000 people annually, most of them children under age 5 in Africa south of the Sahara, and recent efforts to enhance drug oversight in the region, are changing the process.

The World Health Organization stated in a high-level meeting this week that regulatory authorities from at least 10 African countries are currently examining trial data to evaluate the vaccine. It is anticipated that additional countries will grant approval for the vaccine in the next few weeks.

“We expect many more countries to come through,” Mary Hamel, the WHO’s malaria vaccine implementation head, told the expert meeting on Tuesday. “They are sovereign countries that can make their own decisions for their vaccines.”

The countries that could be affected were not specifically identified by her. However, it is worth noting that Tanzania and Kenya have stringent regulatory bodies and comparatively high prevalence rates of the illness.

Leave a Reply

Your email address will not be published. Required fields are marked *